Abionyx Pharma SA banner

Abionyx Pharma SA
F:609

Watchlist Manager
Abionyx Pharma SA Logo
Abionyx Pharma SA
F:609
Watchlist
Price: 1.794 EUR 0.11%
Market Cap: €62.2m

Wall St Price Targets

Price Targets Summary
Abionyx Pharma SA

Wall Street analysts forecast Abionyx Pharma SA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Abionyx Pharma SA is 9.483 EUR with a low forecast of 9.015 EUR and a high forecast of 10.153 EUR.

Lowest Forecast
Price Target
9.015 EUR
402% Upside
Average Forecast
Price Target
9.483 EUR
429% Upside
Highest Forecast
Price Target
10.153 EUR
466% Upside
Abionyx Pharma SA Competitors:
Price Targets
CIGI
Colliers International Group Inc
9% Upside
QLYS
Qualys Inc
-18% Downside
NSIT
Insight Enterprises Inc
-13% Downside

Revenue
Forecast

N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 112%.

Gross Profit
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
30%
Average Beat
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
30%
Average Beat

The compound annual growth rate for Gross Profit over the next 2 years is 24%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Abionyx Pharma SA's stock price target?
Price Target
9.483 EUR

According to Wall Street analysts, the average 1-year price target for Abionyx Pharma SA is 9.483 EUR with a low forecast of 9.015 EUR and a high forecast of 10.153 EUR.

What is the Revenue forecast for Abionyx Pharma SA?
Projected CAGR
112%

The compound annual growth rate for Revenue over the next 3 years is 112%.

What is the Gross Profit forecast for Abionyx Pharma SA?
Projected CAGR
24%

The compound annual growth rate for Gross Profit over the next 2 years is 24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett